StockData
GT Biopharma, Inc. logo

GT Biopharma, Inc. (GTBP) stock

GTBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30
$3.43+0.25 (+7.86%)

Close on Nov 18, 2026Market cap $154.73MP/E –Yield –

GT Biopharma market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

GT Biopharma's market cap was $100.86M on Nov 11, 2026, against $119.54M a year earlier. Over the last 5 years it ranged from $47.99M to $2.55B, with a median of $207.09M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$100.86M-15.1%
2025Dec 31, 2025$118.80M-30.3%
2024Dec 31, 2024$170.37M-35.5%
2023Dec 29, 2023$264.07M-63.5%
2022Dec 30, 2022$723.29M+81.8%
2021Dec 31, 2021$397.92M-97.2%
2020Dec 31, 2020$13.97B+506.6%
2019Dec 31, 2019$2.30B-83.4%
2018Dec 31, 2018$13.88B-85.3%
2017Dec 29, 2017$94.14B–

More GT Biopharma figures

See a number that looks wrong?